The lancet oncology
-
The lancet oncology · Mar 2016
Multicenter StudyA prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
The clinical outcome of extranodal natural killer T-cell lymphoma (ENKTL) has improved substantially as a result of new treatment strategies with non-anthracycline-based chemotherapies and upfront use of concurrent chemoradiotherapy or radiotherapy. A new prognostic model based on the outcomes obtained with these contemporary treatments was warranted. ⋯ Samsung Biomedical Research Institute.
-
The lancet oncology · Mar 2016
Randomized Controlled TrialLong-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Compared with traditional photon radiotherapy, proton radiotherapy irradiates less normal tissue and might improve health outcomes associated with photon radiotherapy by reducing toxic effects to normal tissue. We did a trial to assess late complications, acute side-effects, and survival associated with proton radiotherapy in children with medulloblastoma. ⋯ US National Cancer Institute and Massachusetts General Hospital.
-
The lancet oncology · Mar 2016
Randomized Controlled Trial Comparative StudyBenefits of pazopanib over sunitinib for renal cell carcinoma.